.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Reactive metabolite PTMs (post-translational modifications) represent a critical biochemical link between metabolic activity and cellular homeostasis. These modifications involve the covalent attachment of reactive chemical groups to proteins after their initial synthesis. Consequently, they significantly influence protein stability, subcellular localization, and complex molecular interactions within the cell.
Research highlights that these modifications often occur through non-enzymatic processes. For instance, intermediates from glycolysis or lipid peroxidation can spontaneously react with specific amino acid residues. Therefore, the metabolic state of a cell directly determines its proteomic landscape. Furthermore, these interactions are not just biochemical curiosities but are central to various pathological conditions. Understanding how reactive metabolites alter protein function provides a deeper insight into systemic health and disease.
In the realm of oncology, reactive metabolite PTMs frequently drive oncogenic signaling pathways. Abnormal modifications can stabilize oncoproteins or deactivate tumor suppressors, thereby promoting tumor growth. Additionally, researchers have identified these PTMs as potential biomarkers for early cancer detection and therapeutic monitoring. However, their influence extends beyond cancer.
In hepatology, these modifications play a pivotal role in drug-induced toxicity. A classic example involves reactive metabolites from medications like acetaminophen, which form protein adducts and trigger cellular stress. Moreover, the study of these modifications helps clinicians understand the mechanisms behind metabolic disorders and neurodegenerative diseases. Consequently, high-resolution analysis of these PTMs is becoming a cornerstone of precision medicine.
They are chemical changes to proteins caused by reactive intermediates of metabolism. These modifications can alter a protein's structure and its biological activity.
They can disrupt normal cellular signaling, leading to issues like organ toxicity, inflammation, or the progression of diseases like cancer and diabetes.
Yes, specific reactive metabolite PTMs serve as biomarkers that help clinicians identify metabolic stress or drug-induced injury at an early stage.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional physician-patient relationship. Always seek the advice of a qualified healthcare provider for any medical concerns. Refer to the latest local and national guidelines for clinical practice.
References
Gurajala KC et al. Reactive Metabolite Post-Translational Modifications: Linking Metabolism and Cellular Homeostasis. Chem Res Toxicol. 2026 Mar 23. doi: 10.1021/acs.chemrestox.5c00465. PMID: 41871369.
Zhang B, Schroeder FC. Mechanisms of metabolism-coupled protein modifications. Nat Chem Biol. 2025;21:145-158.
Liu Y et al. Metabolite-derived protein modifications modulating oncogenic signaling. Front Oncol. 2022;12:988626.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A review of how reactive metabolite post-translational modifications (PTMs) impact protein stability, cellular homeostasis, and clinical disease progression...
5 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
